APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,444,429 | -99.1% | 37,991 | -97.9% | 0.00% | -99.0% |
| Q2 2023 | $161,872,148 | -47.6% | 1,776,905 | -62.0% | 0.10% | -50.5% |
| Q1 2023 | $308,778,970 | +49.7% | 4,681,482 | +17.4% | 0.20% | +38.8% |
| Q4 2022 | $206,200,445 | +21268.7% | 3,987,745 | +14004.9% | 0.15% | +14600.0% |
| Q3 2022 | $964,964 | +32.6% | 28,272 | +75.7% | 0.00% | 0.0% |
| Q2 2022 | $728,000 | -10.2% | 16,094 | +0.8% | 0.00% | – |
| Q1 2022 | $811,000 | +7.7% | 15,972 | +0.4% | 0.00% | – |
| Q4 2021 | $753,000 | +274.6% | 15,907 | +161.1% | 0.00% | – |
| Q3 2021 | $201,000 | – | 6,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |